Company: CGCT
Filing Date: 2025-03-05
Form Type: S-1/A
Source: 0001104659-25-020969
Chunk: 167

Company: Cartesian Growth Corp III
Filing Date: 2025-03-05
Form: S-1/A
Chunk 167
---
 initial business combination does not close, we may use amounts
held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment.
Up to $1,500,000 of such loans may be convertible into private placement warrants of the post business combination entity at a price
of $1.00 per warrant at the option of the lender, which conversion may result in material dilution to our public shareholders. Such warrants
would be identical to the private placement warrants. Except as set forth above, the terms of such loans, if any, have not been determined
and no written agreements exist with respect to such loans. Prior to the completion of our initial business combination, we do not expect
to seek loans from parties other than our sponsor or an affiliate of our sponsor as we do not believe third parties will be willing to
loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.

We have until the date that is 24 months from
the closing of this offering, or until such earlier date as our board of directors may approve, to consummate our initial business combination.
If we anticipate that we may be unable to consummate our initial business combination within such 24-month period, we may seek shareholder
approval to amend our amended and restated memorandum and articles of association to extend the date by which we must consummate our
initial business combination. If we seek shareholder approval for an extension, holders of public shares will be offered an opportunity
to redeem their shares at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including
interest earned thereon (less taxes payable, but without deduction for any excise or similar tax that may be due or payable), divided
by the number of then issued and outstanding public shares, subject to applicable law.

<div align='center'>92</div>

Any of the foregoing payments to our initial
shareholders, officers or directors, or our or their affiliates, repayments of loans from our sponsor or repayments of working capital
loans will, prior to our initial business combination, be made using funds held outside the trust account.

As more fully discussed in “Management — Conflicts of Interest,” each of our officers and directors presently has, and any of them in the future may have additional,
fiduciary, contractual or other obligations or duties to one or more other entities, including CGC II, pursuant to which such officer